echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > It's convenient and practical! Do you know this prognostic indicator of renal cell carcinoma?

    It's convenient and practical! Do you know this prognostic indicator of renal cell carcinoma?

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    Guide

    Being able to accurately predict the prognosis of cancer patients is critical
    for clinicians to develop the most appropriate treatment strategy and follow-up plan.


    Research background


    Prognostic Nutrition Index (PNI), a new method for assessing a patient's immune and nutritional status based on serum lymphocyte counts and albumin levels, has been used in several studies to predict the prognosis
    of patients with renal cell carcinoma (RCC).
    However, the impact of PNI on the prognosis of RCC needs to be explored
    in depth due to differences in sample size, patient characteristics, and other factors in existing studies.
    To this end, Korean researchers conducted this meta-analysis to evaluate the diagnostic accuracy and application value
    of PNI as a prognostic factor for RCC based on the available data.


    Study design


    Based on the systematic review and the Meta-Analysis Priority Report Item (PRISMA) statement, the investigators conducted a systematic and comprehensive search of relevant literature in the PubMed, Web of Science, Cochrane Library and EMBASE databases, structured research questions according to PICO principles and screened
    the literature.
    PNI values were calculated using formula 10× albumin concentration (g/dL) + 0.
    005× lymphocyte count (/mm3), and their sensitivity, specificity, combined subject operating characteristic curve (SROC) and area under the curve (AUC)
    were evaluated.


    Research results


    The final meta-analysis included 11 studies
    involving a total of 7296 people with RCC.
    Pooled analysis of PNI data on the prognostic value of RCC showed a sensitivity of 0.
    733 (95% CI 0.
    651 to 0.
    802), specificity of 0.
    615 (95% CI 0.
    528 to 0.
    695), diagnostic odds ratio (DOR) of 4.
    382 (95% CI 3.
    148 to 6.
    101), and AUC of 0.
    72 (95% CI 0.
    68 to 0.
    76).


    Fig.
    1 Forest plot of sensitivity and specificity of PNI for the prognostic value of RCC


    Subgroup analysis showed that the presence of metastasis and PNI cut-off values (≥50 vs <50) affected the diagnostic accuracy<b10> of PNI in RCC.
    Multivariate meta-regression showed a significant difference in sensitivity and specificity between PNI and non-metastatic RCC groups (p=0.
    035).


    Table 1 Univariate and multivariate meta-regression analysis results


    Conclusion of the study


    This study showed that PNI as a prognostic indicator of RCC demonstrated good diagnostic accuracy, especially in
    metastatic RCC.




    Editor's comments

    PNI is an economical, simple, efficient and widely used predictor that reflects the nutritional and immune status of the body and has been shown to be associated
    with the prognosis of a variety of tumors.
    The results of this study further support that PNI can help clinicians predict the clinical outcome of RCC, which is worthy of clinical promotion
    .

    References:

    Shim SR, Kim SI, Kim SJ, Cho DS.
    Prognostic nutritional index as a prognostic factor for renal cell carcinoma: A systematic review and meta-analysis.
    PLoS One.
    2022 Aug 5; 17(8):e0271821.

    This platform aims to deliver more medical information
    to healthcare professionals.
    The content published on this platform cannot replace professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice
    .
    If such information is used for purposes other than understanding medical information, this platform does not assume relevant responsibilities
    .
    The content published by this platform does not mean that it agrees with its description and views
    .
    If copyright issues are involved, please contact us and we will deal with it
    as soon as possible.


    END


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.